CN106310385A - Preparation method and application of egg shell membrane composite nano-silver thin film used for artificial skin - Google Patents
Preparation method and application of egg shell membrane composite nano-silver thin film used for artificial skin Download PDFInfo
- Publication number
- CN106310385A CN106310385A CN201610701664.XA CN201610701664A CN106310385A CN 106310385 A CN106310385 A CN 106310385A CN 201610701664 A CN201610701664 A CN 201610701664A CN 106310385 A CN106310385 A CN 106310385A
- Authority
- CN
- China
- Prior art keywords
- composite nano
- egg
- concentration
- deionized water
- artificial skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 title claims abstract description 64
- 239000002131 composite material Substances 0.000 title claims abstract description 54
- 239000010409 thin film Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 229940012466 egg shell membrane Drugs 0.000 title claims 15
- 235000013601 eggs Nutrition 0.000 claims abstract description 102
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 claims abstract description 76
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 45
- 239000008367 deionised water Substances 0.000 claims abstract description 42
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 42
- 239000010408 film Substances 0.000 claims abstract description 41
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229960003638 dopamine Drugs 0.000 claims abstract description 38
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 claims abstract description 35
- 102000002322 Egg Proteins Human genes 0.000 claims abstract description 18
- 108010000912 Egg Proteins Proteins 0.000 claims abstract description 18
- 229910001961 silver nitrate Inorganic materials 0.000 claims abstract description 15
- 210000002969 egg yolk Anatomy 0.000 claims abstract description 8
- 238000004140 cleaning Methods 0.000 claims abstract 2
- 235000013345 egg yolk Nutrition 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 58
- 206010052428 Wound Diseases 0.000 claims description 23
- 208000027418 Wounds and injury Diseases 0.000 claims description 23
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 230000007547 defect Effects 0.000 claims description 10
- 239000000872 buffer Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 206010040872 skin infection Diseases 0.000 claims description 2
- 241000287828 Gallus gallus Species 0.000 claims 2
- 208000028990 Skin injury Diseases 0.000 claims 2
- 210000004681 ovum Anatomy 0.000 claims 2
- 239000007864 aqueous solution Substances 0.000 claims 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 claims 1
- 239000012528 membrane Substances 0.000 abstract description 97
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 16
- 210000003278 egg shell Anatomy 0.000 abstract description 8
- 210000000969 egg white Anatomy 0.000 abstract description 8
- 235000014103 egg white Nutrition 0.000 abstract description 8
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 abstract description 7
- 231100000419 toxicity Toxicity 0.000 abstract description 3
- 230000001988 toxicity Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000002791 soaking Methods 0.000 abstract 1
- 210000004379 membrane Anatomy 0.000 description 95
- 210000003491 skin Anatomy 0.000 description 42
- 238000002474 experimental method Methods 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 230000029663 wound healing Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 108010023728 Alloderm Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229940099259 vaseline Drugs 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 238000003917 TEM image Methods 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001523 electrospinning Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000002744 extracellular matrix Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 238000011056 performance test Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 102000012422 Collagen Type I Human genes 0.000 description 1
- 108010022452 Collagen Type I Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000008960 Diabetic foot Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 206010014418 Electrolyte imbalance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000002260 Keloid Diseases 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- QGMRQYFBGABWDR-UHFFFAOYSA-M Pentobarbital sodium Chemical compound [Na+].CCCC(C)C1(CC)C(=O)NC(=O)[N-]C1=O QGMRQYFBGABWDR-UHFFFAOYSA-M 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 210000002469 basement membrane Anatomy 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000013043 cell viability test Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000002828 disc diffusion antibiotic sensitivity testing Methods 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000001969 hypertrophic effect Effects 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000001117 keloid Anatomy 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229960002275 pentobarbital sodium Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- -1 silver ions Chemical class 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 231100000378 teratogenic Toxicity 0.000 description 1
- 230000003390 teratogenic effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
- A61L2300/104—Silver, e.g. silver sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Materials Engineering (AREA)
- Urology & Nephrology (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法及应用,所述制备方法包括:将新鲜鸡蛋弃掉蛋清和蛋黄,用去离子水清洗鸡蛋壳,分离鸡蛋膜,然后再用去离子水清洗,剪成1—3cm×1—3cm大小,置于浓度为1—100mM,pH=1—3的盐酸溶液中,室温下浸泡1—4天后用去离子水清洗,然后置于浓度为2—4mg/mL,pH=8.5—9.5的多巴胺溶液中,室温下浸6—20h后用去离子水清洗,再置于浓度为10—50nM硝酸银溶液中,室温下避光浸泡6—20h后用去离子水清洗,常温下自然干燥,得到用于人工皮肤的鸡蛋膜复合纳米银薄膜。制得的鸡蛋膜复合纳米银薄膜用于制造人工皮肤,具有良好的抗菌性能,无明显生物毒性,制备方法工艺简单,耗时少,成本低。
The invention discloses a preparation method and application of an egg film composite nano-silver film for artificial skin. The preparation method includes: discarding the egg white and egg yolk of fresh eggs, cleaning the egg shell with deionized water, separating the egg film, Then wash it with deionized water, cut it into a size of 1-3cm×1-3cm, put it in a hydrochloric acid solution with a concentration of 1-100mM and pH=1-3, soak it at room temperature for 1-4 days, and then wash it with deionized water. Then put it in a dopamine solution with a concentration of 2-4mg/mL and pH=8.5-9.5, soak it for 6-20 hours at room temperature, wash it with deionized water, and then put it in a silver nitrate solution with a concentration of 10-50nM. After soaking in light for 6-20 hours, it is washed with deionized water and dried naturally at normal temperature to obtain an egg membrane composite nano-silver thin film for artificial skin. The prepared egg membrane composite nano-silver thin film is used to manufacture artificial skin, has good antibacterial properties, has no obvious biological toxicity, and has a simple preparation process, less time-consuming and low cost.
Description
技术领域technical field
本发明属材料应用技术领域,具体涉及一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法及应用。The invention belongs to the technical field of material application, and in particular relates to a preparation method and application of an egg membrane composite nano-silver thin film for artificial skin.
背景技术Background technique
皮肤作为人体最大的器官,可以保护内部器官免受损伤并且维持水电解质平衡。烧伤、创伤、糖尿病足溃疡等引起的皮肤缺损,会导致机体出现严重的感染、水电解质失衡、瘢痕增生等问题,给病人带来巨大的精神和身体痛苦以及沉重的医疗负担。因此,恢复皮肤的屏障功能成为当务之急。然而,部分皮肤缺损较大的患者,如大面积烧烫伤病人,由于自身皮源有限,无法及时有效封闭创面。为解决这个问题,应用一种合适的人工皮肤来替代自身皮源封闭创面是十分必要的。As the largest organ of the human body, the skin can protect internal organs from damage and maintain water and electrolyte balance. Skin defects caused by burns, trauma, diabetic foot ulcers, etc. will lead to serious infection, water and electrolyte imbalance, scar hyperplasia and other problems in the body, which will bring huge mental and physical pain and heavy medical burden to patients. Therefore, restoring the barrier function of the skin has become a top priority. However, some patients with large skin defects, such as patients with extensive burns, cannot effectively seal the wound in time due to their limited skin source. In order to solve this problem, it is very necessary to apply a suitable artificial skin to replace the self-skin source to seal the wound.
目前,国外已有Integra、AlloDerm等许多商品化的人工皮肤应用于临床。Integra是由Burke 和Yannas 于1980年开发的一种人工皮肤。它由硅橡胶薄膜构成“表皮”,戊二醛交联的牛Ⅰ型胶原与6-硫酸软骨素及氨基葡萄糖构成“真皮”。临床应用发现其有利于创面组织的浸润生长, 易于血管化且不易降解, 可以有效促进大面积烧伤创面的愈合,同时,对防治瘢痕疙瘩和增生性瘢痕也有明显效果。然而,该人工皮肤对创面要求较高,抗感染能力弱,且力学强度和透气性能也较差,同时,由于制备工艺复杂,价格昂贵,其难以广泛推广。 AlloDerm则是由美国Life Science公司生产的一种商品化脱细胞真皮基质,它是将新鲜尸体皮的表皮和细胞成分去除后制成的人工皮肤,因为去除了细胞成分, 所以AlloDerm降低了免疫原性, 但其仍保留了细胞外基质支架的三维结构以及完整的基底膜复合体,可引导新生细胞生长扩展。但是,由于尸体皮源有限,且有传播病毒的危险,同时AlloDerm价格昂贵,工艺复杂,其应用也受到限制。At present, many commercialized artificial skins such as Integra and AlloDerm have been used clinically abroad. Integra is an artificial skin developed by Burke and Yannas in 1980. It consists of a silicone rubber film to form the "epidermis", glutaraldehyde-crosslinked bovine type I collagen, chondroitin 6-sulfate and glucosamine to form the "dermis". Clinical application has found that it is beneficial to the infiltration and growth of wound tissue, easy to vascularize and not easy to degrade, and can effectively promote the healing of large area burn wounds. At the same time, it also has obvious effects on the prevention and treatment of keloids and hypertrophic scars. However, the artificial skin has high requirements on the wound surface, weak anti-infection ability, and poor mechanical strength and air permeability. At the same time, due to the complicated preparation process and high price, it is difficult to be widely promoted. AlloDerm is a commercial decellularized dermal matrix produced by American Life Science Company. It is an artificial skin made by removing the epidermis and cellular components of fresh cadaver skin. Because the cellular components are removed, AlloDerm reduces the immunogen However, it still retains the three-dimensional structure of the extracellular matrix scaffold and the complete basement membrane complex, which can guide the growth and expansion of newborn cells. However, due to the limited source of cadaver skin and the risk of virus transmission, AlloDerm is expensive and complicated in process, so its application is also limited.
因此,制备一种价格低廉、操作工艺相对简单,且生物相容性好、抗菌效果佳的人工皮肤显得尤为重要。Therefore, it is particularly important to prepare an artificial skin with low price, relatively simple operation process, good biocompatibility and good antibacterial effect.
支架材料的性能是构建人工皮肤的关键因素,也是该领域的研究热点。鸡蛋膜,是位于鸡蛋壳与蛋清之间的一种纤维网状薄膜,具有良好的透气性能及力学特性。鸡蛋膜主要由角蛋白、胶原蛋白等蛋白质构成,同时还含有透明质酸、硫酸软骨素等构成细胞外基质的主要成分。作为一种天然生物支架材料,其具有良好的生物组织相容性,并且无毒、无免疫原性。此外,鸡蛋膜易于获取,价格低廉,可以简单经济地在临床上广泛应用。目前,其已经用于某些表浅皮肤创面的治疗。The performance of scaffold materials is a key factor in the construction of artificial skin, and it is also a research hotspot in this field. Egg membrane is a fibrous mesh film located between egg shell and egg white, with good air permeability and mechanical properties. The egg membrane is mainly composed of proteins such as keratin and collagen, and also contains hyaluronic acid, chondroitin sulfate and other main components of the extracellular matrix. As a natural bioscaffold material, it has good biocompatibility, and is non-toxic and non-immunogenic. In addition, egg membranes are easy to obtain and cheap, and can be widely used in clinic simply and economically. At present, it has been used in the treatment of some superficial skin wounds.
纳米银是一种广泛使用的医用抗菌剂,对细菌、真菌等具有良好的杀灭效果。同时,纳米银抗菌持续且稳定,少有耐药性。研究已证实,纳米银能通过抗菌抗炎有效促进创面愈合。因此,纳米银可以有效地作为人工皮肤中的抗菌制剂发挥作用。然而,纳米银在空气中与氧接触后易形成氧化银,使其抗菌效能大大降低甚至消失。近年来研究发现,将纳米银整合到生物支架上可以有效地保持其稳定性和抗菌性。Nano-silver is a widely used medical antibacterial agent, which has a good killing effect on bacteria and fungi. At the same time, nano-silver antibacterial is sustained and stable, with little drug resistance. Studies have confirmed that nano silver can effectively promote wound healing through antibacterial and anti-inflammatory. Therefore, nanosilver can effectively function as an antibacterial agent in artificial skin. However, nano-silver is easy to form silver oxide after contacting with oxygen in the air, which greatly reduces or even disappears its antibacterial effect. In recent years, studies have found that integrating nano-silver into biological scaffolds can effectively maintain its stability and antibacterial properties.
目前制备纳米银并将其整合到生物支架制备人工皮肤的方法较多,包括静电纺丝技术,应用还原试剂等。但是,静电纺丝技术操作相对复杂,成本较高,而常用的还原试剂需时较多且易产生环境污染物。近年来,Messersmith发现多巴胺能够在各种材料的表面自我聚合形成一层聚合多巴胺薄膜,该薄膜可以高效地粘附多种分子或者细胞。而聚合多巴胺具有还原性,可以在材料表面原位将银离子还原成纳米银颗粒。研究证实,这类纳米银具有良好的稳定性及抗菌性。此外,多巴胺无毒、无致畸作用,具有良好的生物组织相容性,可以有效应用于人工皮肤的制备。At present, there are many methods for preparing nano-silver and integrating it into biological scaffolds to prepare artificial skin, including electrospinning technology and application of reducing reagents. However, the operation of electrospinning technology is relatively complicated and the cost is high, and the commonly used reducing reagents take more time and are prone to produce environmental pollutants. In recent years, Messersmith discovered that dopamine can self-polymerize on the surface of various materials to form a layer of polymerized dopamine film, which can efficiently adhere to various molecules or cells. Polymerized dopamine has reducibility, and can reduce silver ions to nano silver particles in situ on the surface of the material. Studies have confirmed that this kind of nano-silver has good stability and antibacterial properties. In addition, dopamine is non-toxic, non-teratogenic, has good biocompatibility, and can be effectively used in the preparation of artificial skin.
综上,以鸡蛋膜为生物支架,利用多巴胺的粘附及还原特性,制备一种鸡蛋膜复合纳米银的抗菌人工皮肤是一种方便可行,简单实用的方法。In summary, it is a convenient, feasible, simple and practical method to prepare an antibacterial artificial skin made of egg membrane composited with nano-silver by using the egg membrane as a biological scaffold and utilizing the adhesion and reduction properties of dopamine.
发明内容Contents of the invention
本发明的目的是提供一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法。本发明制备的用于人工皮肤的鸡蛋膜复合纳米银薄膜的抗菌性能良好,无明显生物毒性,可有效促进全层皮肤缺损创面的修复,其制备方法具有工艺简单、耗时少、成本低的优点。The purpose of the present invention is to provide a method for preparing egg membrane composite nano-silver thin film for artificial skin. The egg membrane composite nano-silver thin film for artificial skin prepared by the invention has good antibacterial properties, no obvious biological toxicity, and can effectively promote the repair of full-thickness skin defect wounds. The preparation method has the advantages of simple process, less time-consuming and low cost. advantage.
本发明提供一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:The invention provides a method for preparing an egg membrane composite nano-silver film for artificial skin, comprising the following steps:
(1)取新鲜鸡蛋,弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,分离鸡蛋膜,再用去离子水清洗后,将鸡蛋膜剪成1—3cm×1—3cm大小;(1) Take fresh eggs, discard the egg whites and yolks, wash the egg shells in deionized water, separate the egg membranes, wash them with deionized water, and cut the egg membranes into 1-3cm×1-3cm sizes;
(2)将步骤(1)制得的鸡蛋膜置于浓度为1—100mM,pH=1—3的盐酸溶液中,室温下浸泡1—4天,然后用去离子水清洗3—5遍,每遍3—5分钟;(2) Place the egg membrane prepared in step (1) in a hydrochloric acid solution with a concentration of 1-100mM and pH=1-3, soak it at room temperature for 1-4 days, and then wash it with deionized water for 3-5 times, 3-5 minutes each time;
(3)将多巴胺溶入浓度为10—100mM的Tris—HCl缓冲液中,制得浓度为2—4mg/mL的多巴胺溶液,将pH调节至8.5—9.5;(3) Dissolve dopamine in Tris-HCl buffer solution with a concentration of 10-100mM to prepare a dopamine solution with a concentration of 2-4mg/mL, and adjust the pH to 8.5-9.5;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡6—20h,然后用去离子水清洗3—5遍,每遍3—5分钟;(4) Put the egg membrane prepared in step (2) into the dopamine solution prepared in step (3), soak it at room temperature for 6-20 hours, and then wash it with deionized water for 3-5 times, each time for 3-5 minutes ;
(5)将步骤(4)制得的鸡蛋膜置于浓度为10—50nM硝酸银溶液中,室温下避光浸泡6—20h,然后用去离子水清洗3—5遍,每遍3—5分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution with a concentration of 10-50nM, soak it in the dark at room temperature for 6-20h, and then wash it with deionized water for 3-5 times, each time 3-5 Minutes, natural drying at room temperature, prepared egg membrane composite nano-silver thin film.
进一步,所述步骤(1)、步骤(2)和步骤(4)制得的鸡蛋膜用去离子水清洗3遍,每遍5分钟。Further, the egg membranes prepared in the steps (1), (2) and (4) were washed with deionized water for 3 times, 5 minutes each time.
进一步,所述步骤(2)的盐酸溶液的浓度为1mM,pH=3。Further, the concentration of the hydrochloric acid solution in the step (2) is 1 mM, pH=3.
进一步,所述步骤(3)的Tris—HCl缓冲液浓度为10mM。Further, the concentration of the Tris-HCl buffer in the step (3) is 10 mM.
进一步,所述步骤(3)制得的多巴胺溶液浓度为2mg/mL,pH=8.5。Further, the dopamine solution prepared in the step (3) has a concentration of 2 mg/mL and a pH of 8.5.
进一步,所述步骤(5)的硝酸银溶液的浓度为30nM。Further, the concentration of the silver nitrate solution in the step (5) is 30nM.
一种用于人工皮肤的鸡蛋膜复合纳米银薄膜在制备用于治疗皮肤缺损的人工皮肤或外科敷料中的用途。The invention discloses a use of an egg membrane composite nano-silver film for artificial skin in the preparation of artificial skin or surgical dressing for treating skin defects.
进一步,所述皮肤缺损是皮肤全层缺损或皮肤感染创面。Further, the skin defect is a full-thickness skin defect or a skin infection wound.
对本发明的鸡蛋膜复合纳米银薄膜进行以下性能测试。Carry out following performance test to egg membrane composite nano-silver thin film of the present invention.
1.扫描电镜观察:1. Scanning electron microscope observation:
参见图1,采用扫描电子显微镜在不同倍数下观察制得的鸡蛋膜复合纳米银薄膜的表面结构。使用Image-Pro Plus 6.0软件,测量所有电镜图片薄膜的孔隙率,导出到Excel表格中,计算孔隙率平均值及标准差得:薄膜的孔隙率为45±4.11%。Referring to Fig. 1, the surface structure of the prepared egg membrane composite nano-silver thin film was observed under different magnifications by scanning electron microscope. Using Image-Pro Plus 6.0 software, measure the porosity of all electron microscope images of the film, export to an Excel table, calculate the average value and standard deviation of the porosity: the porosity of the film is 45±4.11%.
2.透射电镜观察:2. Transmission electron microscope observation:
参见图2和图3,将制得的鸡蛋膜复合纳米银薄膜用超声粉碎仪粉碎,溶于去离子水中,吹打均匀形成悬液,取一滴悬液滴至炭包被的铜网上,采用透射电子显微镜观察制得的鸡蛋膜复合纳米银薄膜中纳米银的形态及大小。使用Image-J软件,设置标尺为图例标尺,固定选择该标尺,测量所有纳米银颗粒直径,导出到Excel表格中,计算纳米银大小分布图,参见图3,并求得平均值:纳米银的直径为13.91nm。Referring to Figure 2 and Figure 3, the prepared egg membrane composite nano-silver film was pulverized with an ultrasonic pulverizer, dissolved in deionized water, blown and beaten evenly to form a suspension, and a drop of the suspension was dropped onto a carbon-coated copper grid, and was analyzed by transmission. The shape and size of nano-silver in the egg membrane composite nano-silver thin film was observed by electron microscope. Using Image-J software, set the scale as the legend scale, select the scale fixedly, measure the diameters of all nano-silver particles, export them to an Excel table, calculate the size distribution map of nano-silver, see Figure 3, and obtain the average value: The diameter is 13.91nm.
本发明的有益效果是:与现有技术相比,本发明以鸡蛋膜为生物支架,利用多巴胺的粘附和还原特性,纳米银的抗菌性,制备一种用于人工皮肤的鸡蛋膜复合纳米银薄膜,具有良好的抗菌性能,无明显的生物毒性;制备方法成本低,耗时少,操作工艺简单。The beneficial effects of the present invention are: compared with the prior art, the present invention uses the egg membrane as a biological scaffold, utilizes the adhesion and reduction properties of dopamine, and the antibacterial properties of nano silver to prepare an egg membrane composite nanometer for artificial skin. The silver thin film has good antibacterial performance and no obvious biological toxicity; the preparation method has low cost, less time consumption and simple operation process.
附图说明Description of drawings
图1是本发明一个实施例的鸡蛋膜复合纳米银薄膜的扫描电子显微镜照片。Fig. 1 is a scanning electron micrograph of an egg membrane composite nano-silver thin film according to an embodiment of the present invention.
图2是本发明一个实施例的鸡蛋膜复合纳米银薄膜的透射电子显微镜照片。Fig. 2 is a transmission electron micrograph of an egg membrane composite nano-silver thin film according to an embodiment of the present invention.
图3是本发明一个实施例的鸡蛋膜复合纳米银薄膜的透射电子显微镜照片中纳米银的大小分布图。Fig. 3 is a size distribution diagram of nano-silver in a transmission electron micrograph of an egg membrane composite nano-silver thin film according to an embodiment of the present invention.
图4是制备的鸡蛋膜复合纳米银薄膜的细胞相容性实验中的细胞活性柱状图。Fig. 4 is a histogram of cell activity in the cytocompatibility experiment of the prepared egg membrane composite nano-silver thin film.
图5显示制备的鸡蛋膜复合纳米银薄膜的抗菌性能检测实验结果(a—无菌滤纸片、b—盐酸处理后的鸡蛋膜、c—多巴胺溶液处理的鸡蛋膜、d—鸡蛋膜复合纳米银薄膜)。Figure 5 shows the antibacterial performance test results of the prepared egg membrane composite nano silver film (a—sterile filter paper sheet, b—egg membrane treated with hydrochloric acid, c—egg membrane treated with dopamine solution, d—egg membrane composite nano silver film).
图6显示动物实验分别在使用空白对照组、凡士林纱布、盐酸处理后的鸡蛋膜、多巴胺溶液处理后的鸡蛋膜和鸡蛋膜复合纳米银薄膜处理创面后第三天和第七天小鼠创面愈合的比较。Figure 6 shows the wound healing of mice on the third day and the seventh day after the wound was treated with the blank control group, Vaseline gauze, hydrochloric acid-treated egg membrane, dopamine solution-treated egg membrane, and egg membrane composite nano-silver film in animal experiments Comparison.
具体实施方式detailed description
实施例1:一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:Embodiment 1: a kind of preparation method of the egg membrane composite nano-silver thin film that is used for artificial skin, comprises the steps:
(1)取新鲜鸡蛋,轻轻敲碎后弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,然后用镊子小心分离鸡蛋膜,再次用去离子水清洗后,将鸡蛋膜剪成2cm×2cm大小;(1) Take a fresh egg, break it lightly, discard the egg white and yolk, wash the egg shell in deionized water, then carefully separate the egg membrane with tweezers, wash it again with deionized water, and cut the egg membrane into 2cm ×2cm size;
(2)将步骤(1)制得的鸡蛋膜置于盐酸溶液中,室温下浸泡3天,然后用去离子水清洗3遍,每遍5分钟,所述盐酸溶液的浓度为1mM,pH=3;(2) Place the egg membrane prepared in step (1) in a hydrochloric acid solution, soak it at room temperature for 3 days, and then wash it with deionized water for 3 times, each time for 5 minutes. The concentration of the hydrochloric acid solution is 1mM, and the pH= 3;
(3)将多巴胺溶入Tris—HCl溶液中,所述Tris—HCl溶液浓度为10mM,制得的多巴胺溶液浓度为2mg/ml,pH调节至8.5;(3) Dissolving dopamine into Tris-HCl solution, the concentration of the Tris-HCl solution is 10mM, the concentration of the prepared dopamine solution is 2mg/ml, and the pH is adjusted to 8.5;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡16h,然后用去离子水清洗3遍,每遍5分钟;(4) Place the egg membrane prepared in step (2) in the dopamine solution prepared in step (3), soak it at room temperature for 16 hours, and then wash it with deionized water for 3 times, each time for 5 minutes;
(5)将步骤(4)制得的鸡蛋膜置于硝酸银溶液中,所述硝酸银(5)溶液的浓度为30nM,室温下避光浸泡18h,然后用去离子水清洗3遍,每遍5分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution, the concentration of the silver nitrate (5) solution is 30nM, soak for 18 hours in the dark at room temperature, and then wash it with deionized water 3 times, each Repeat for 5 minutes, and dry naturally at room temperature to prepare egg membrane composite nano-silver thin film.
实施例2:一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:Embodiment 2: a kind of preparation method of egg membrane composite nano-silver film for artificial skin comprises the following steps:
(1)取新鲜鸡蛋,轻轻敲碎后弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,然后用镊子小心分离鸡蛋膜,再次用去离子水清洗后,将鸡蛋膜剪成1cm×3cm大小;(1) Take a fresh egg, break it lightly, discard the egg white and yolk, wash the egg shell in deionized water, then carefully separate the egg membrane with tweezers, wash it again with deionized water, and cut the egg membrane into 1cm ×3cm size;
(2)将步骤(1)制得的鸡蛋膜置于盐酸溶液中,室温下浸泡1天,然后用去离子水清洗3遍,每遍5分钟,所述盐酸溶液的浓度为10mM,pH=1;(2) Place the egg membrane prepared in step (1) in hydrochloric acid solution, soak it at room temperature for 1 day, and then wash it with deionized water for 3 times, each time for 5 minutes. The concentration of the hydrochloric acid solution is 10mM, and the pH= 1;
(3)将多巴胺溶入Tris—HCl溶液中,所述Tris—HCl溶液浓度为30mM,制得的多巴胺溶液浓度为2mg/ml,pH调节至9.0;(3) Dissolving dopamine into Tris-HCl solution, the concentration of the Tris-HCl solution is 30mM, the concentration of the prepared dopamine solution is 2mg/ml, and the pH is adjusted to 9.0;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡6h,然后用去离子水清洗3遍,每遍5分钟;(4) Put the egg membrane prepared in step (2) into the dopamine solution prepared in step (3), soak it at room temperature for 6 hours, and then wash it with deionized water for 3 times, each time for 5 minutes;
(5)将步骤(4)制得的鸡蛋膜置于硝酸银溶液中,所述硝酸银(5)溶液的浓度为10nM,室温下避光浸泡6h,然后用去离子水清洗3遍,每遍5分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution, the concentration of the silver nitrate (5) solution is 10nM, soak for 6 hours in the dark at room temperature, and then wash it with deionized water for 3 times. Repeat for 5 minutes, and dry naturally at room temperature to prepare egg membrane composite nano-silver thin film.
实施例3:一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:Embodiment 3: a kind of preparation method of egg membrane composite nano-silver thin film for artificial skin, comprises the steps:
(1)取新鲜鸡蛋,轻轻敲碎后弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,然后用镊子小心分离鸡蛋膜,再次用去离子水清洗后,将鸡蛋膜剪成3cm×3cm大小;(1) Take a fresh egg, break it lightly, discard the egg white and yolk, wash the egg shell in deionized water, then carefully separate the egg membrane with tweezers, wash it again with deionized water, and cut the egg membrane into 3cm ×3cm size;
(2)将步骤(1)制得的鸡蛋膜置于盐酸溶液中,室温下浸泡4天,然后用去离子水清洗5遍,每遍3分钟,所述盐酸溶液的浓度为100mM,pH=3;(2) Place the egg membrane prepared in step (1) in a hydrochloric acid solution, soak it at room temperature for 4 days, and then wash it with deionized water for 5 times, each time for 3 minutes. The concentration of the hydrochloric acid solution is 100mM, and the pH= 3;
(3)将多巴胺溶入Tris—HCl溶液中,所述Tris—HCl溶液浓度为100mM,制得的多巴胺溶液浓度为4mg/ml,pH调节至9.5;(3) Dissolving dopamine into Tris-HCl solution, the concentration of the Tris-HCl solution is 100mM, the concentration of the prepared dopamine solution is 4mg/ml, and the pH is adjusted to 9.5;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡20h,然后用去离子水清洗5遍,每遍3分钟;(4) Put the egg membrane prepared in step (2) into the dopamine solution prepared in step (3), soak it at room temperature for 20 hours, and then wash it with deionized water for 5 times, each time for 3 minutes;
(5)将步骤(4)制得的鸡蛋膜置于硝酸银溶液中,所述硝酸银(5)溶液的浓度为50nM,室温下避光浸泡20h,然后用去离子水清洗5遍,每遍3分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution, the concentration of the silver nitrate (5) solution is 50nM, soak it in the dark at room temperature for 20h, and then wash it with deionized water for 5 times. Repeat for 3 minutes, and dry naturally at room temperature to prepare egg membrane composite nano-silver thin film.
实施例4:一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:Embodiment 4: a kind of preparation method of the egg membrane composite nano-silver thin film that is used for artificial skin, comprises the steps:
(1)取新鲜鸡蛋,轻轻敲碎后弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,然后用镊子小心分离鸡蛋膜,再次用去离子水清洗后,将鸡蛋膜剪成2cm×3cm大小;(1) Take a fresh egg, break it lightly, discard the egg white and yolk, wash the egg shell in deionized water, then carefully separate the egg membrane with tweezers, wash it again with deionized water, and cut the egg membrane into 2cm ×3cm size;
(2)将步骤(1)制得的鸡蛋膜置于盐酸溶液中,室温下浸泡2天,然后用去离子水清洗4遍,每遍4分钟,所述盐酸溶液的浓度为40mM,pH=2;(2) Place the egg membrane prepared in step (1) in a hydrochloric acid solution, soak it at room temperature for 2 days, and then wash it with deionized water for 4 times, each time for 4 minutes. The concentration of the hydrochloric acid solution is 40mM, and the pH= 2;
(3)将多巴胺溶入Tris—HCl溶液中,所述Tris—HCl溶液浓度为50mM,制得的多巴胺溶液浓度为3mg/ml,pH调节至8.5;(3) Dissolving dopamine into Tris-HCl solution, the concentration of the Tris-HCl solution is 50mM, the concentration of the prepared dopamine solution is 3mg/ml, and the pH is adjusted to 8.5;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡14h,然后用去离子水清洗4遍,每遍4分钟;(4) Put the egg membrane prepared in step (2) into the dopamine solution prepared in step (3), soak it at room temperature for 14 hours, and then wash it with deionized water 4 times, each time for 4 minutes;
(5)将步骤(4)制得的鸡蛋膜置于硝酸银溶液中,所述硝酸银(5)溶液的浓度为40nM,室温下避光浸泡12h,然后用去离子水清洗4遍,每遍4分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution, the concentration of the silver nitrate (5) solution is 40nM, soak for 12 hours in the dark at room temperature, and then wash it with deionized water 4 times, every Repeat for 4 minutes, and dry naturally at room temperature to prepare egg membrane composite nano-silver thin film.
实施例5:一种用于人工皮肤的鸡蛋膜复合纳米银薄膜的制备方法,包括如下步骤:Embodiment 5: a kind of preparation method of the egg membrane composite nano-silver thin film that is used for artificial skin, comprises the steps:
(1)取新鲜鸡蛋,轻轻敲碎后弃掉蛋清和蛋黄,将鸡蛋壳置于去离子水中清洗,然后用镊子小心分离鸡蛋膜,再次用去离子水清洗后,将鸡蛋膜剪成3cm×2cm大小;(1) Take a fresh egg, break it lightly, discard the egg white and yolk, wash the egg shell in deionized water, then carefully separate the egg membrane with tweezers, wash it again with deionized water, and cut the egg membrane into 3cm ×2cm size;
(2)将步骤(1)制得的鸡蛋膜置于盐酸溶液中,室温下浸泡3天,然后用去离子水清洗5遍,每遍4分钟,所述盐酸溶液的浓度为80mM,pH=3;(2) Place the egg membrane prepared in step (1) in a hydrochloric acid solution, soak it at room temperature for 3 days, and then wash it with deionized water for 5 times, each time for 4 minutes. The concentration of the hydrochloric acid solution is 80mM, and the pH= 3;
(3)将多巴胺溶入Tris—HCl溶液中,所述Tris—HCl溶液浓度为70mM,制得的多巴胺溶液浓度为4mg/ml,pH调节至9.5;(3) Dissolving dopamine into Tris-HCl solution, the concentration of the Tris-HCl solution is 70mM, the concentration of the prepared dopamine solution is 4mg/ml, and the pH is adjusted to 9.5;
(4)将步骤(2)制得的鸡蛋膜置于步骤(3)制得的多巴胺溶液中,室温下浸泡10h,然后用去离子水清洗5遍,每遍4分钟;(4) Put the egg membrane prepared in step (2) into the dopamine solution prepared in step (3), soak it at room temperature for 10 hours, and then wash it with deionized water for 5 times, each time for 4 minutes;
(5)将步骤(4)制得的鸡蛋膜置于硝酸银溶液中,所述硝酸银(5)溶液的浓度为40nM,室温下避光浸泡14h,然后用去离子水清洗5遍,每遍4分钟,常温下自然干燥,制得鸡蛋膜复合纳米银薄膜。(5) Place the egg membrane prepared in step (4) in a silver nitrate solution, the concentration of the silver nitrate (5) solution is 40nM, soak for 14 hours in the dark at room temperature, and then wash it with deionized water for 5 times. Repeat for 4 minutes, and dry naturally at room temperature to prepare egg membrane composite nano-silver thin film.
实施例6:对制得的鸡蛋膜复合纳米银薄膜进行细胞相容性实验为检验制备的用于人工皮肤的鸡蛋膜复合纳米银薄膜的细胞相容性,进行如下实验:Embodiment 6: Carry out cytocompatibility experiment to the prepared egg membrane composite nano-silver film For the cytocompatibility of the prepared egg membrane composite nano-silver film for artificial skin, the following experiment is carried out:
(1)实验分组:实验组:鸡蛋膜复合纳米银薄膜;对照组:盐酸处理后的鸡蛋膜和多巴胺处理的鸡蛋膜;(1) Experimental grouping: experimental group: egg membrane composited with nano-silver film; control group: egg membrane treated with hydrochloric acid and egg membrane treated with dopamine;
(2)将由实施例1制得的实验组样本和对照组样本分别用打孔器制成直径为6mm的薄膜圆盘,浸泡于75%乙醇溶液中消毒后用磷酸盐缓冲液漂洗3次;(2) The samples of the experimental group and the control group prepared in Example 1 were respectively made into film discs with a diameter of 6 mm by a puncher, soaked in 75% ethanol solution for disinfection, and then rinsed with phosphate buffer for 3 times;
(3)将无菌圆盘分别置于96孔板中,每组复种6孔;(3) Place the sterile discs in 96-well plates, and replant 6 wells in each group;
(4)取对数生长期GFP小鼠成纤维细胞,每孔接种8×103细胞至薄膜圆盘上,加入含10%胎牛血清的DMEM培养基至200μL,24小时细胞贴壁生长后换液;(4) Take GFP mouse fibroblasts in the logarithmic growth phase, inoculate 8×10 3 cells per well on a film disc, add DMEM medium containing 10% fetal bovine serum to 200 μL, and grow cells adherently for 24 hours change fluid;
(5)培养后第3天, 取每组各3个孔的薄膜于荧光显微镜下观察细胞粘附及生长形态;剩余3孔进行细胞增殖检测实验,弃去原培养基,每孔加入100μL新的培养基和10μL 的MTT试剂,37℃下孵育4小时,然后弃去培养基,加入100μl 二甲基亚砜以溶解薄膜上的紫色结晶,摇床上摇晃10分钟后,利用酶标仪在570nm波长处检测每孔的光密度,绘制柱状图,检测鸡蛋膜复合纳米银对细胞活性的影响。(5) On the 3rd day after culture, take the films of 3 wells in each group and observe the cell adhesion and growth morphology under a fluorescence microscope; the remaining 3 wells are used for cell proliferation detection experiments, the original medium is discarded, and 100 μL of new medium is added to each well. culture medium and 10 μL MTT reagent, incubate at 37°C for 4 hours, then discard the medium, add 100 μl dimethyl sulfoxide to dissolve the purple crystals on the film, shake on the shaker for 10 minutes, use a microplate reader at 570nm The optical density of each well was detected at the wavelength, and a histogram was drawn to detect the effect of egg membrane composite nano-silver on cell activity.
结果:参见图4,镜下可见三组细胞均生长较好,呈典型的梭形展开,而细胞活性检测显示鸡蛋膜复合纳米银与多巴胺处理的鸡蛋膜组无明显差异,提示纳米银的加入未引起明显细胞毒性,安全性较好。多巴胺处理后鸡蛋膜较未浸泡多巴胺的鸡蛋膜明显促进细胞生长,说明多巴胺具有良好的生物相容性。Results: See Figure 4. Under the microscope, it can be seen that the cells in the three groups all grew well, showing a typical spindle-shaped expansion, and the cell viability test showed that there was no significant difference between the egg membrane composite nano-silver group and the dopamine-treated egg membrane group, suggesting the addition of nano-silver It did not cause obvious cytotoxicity and was relatively safe. Egg membranes treated with dopamine significantly promoted cell growth compared with egg membranes not soaked in dopamine, indicating that dopamine has good biocompatibility.
实施例7:对制得的鸡蛋膜复合纳米银薄膜的进行抗菌性能检测实验Embodiment 7: Carrying out the antibacterial performance detection experiment of the egg membrane composite nano-silver thin film that makes
为检验制备的用于人工皮肤的鸡蛋膜复合纳米银薄膜的抗菌性能,应用纸片扩散法进行以下实验:In order to test the antibacterial performance of the prepared egg membrane composite nano-silver film for artificial skin, the following experiments were carried out by using the disc diffusion method:
(1)实验分组:实验组:实施例1制得的鸡蛋膜复合纳米银薄膜;对照组:无菌滤纸片盐酸处理后的鸡蛋膜,多巴胺溶液处理后的鸡蛋膜;(1) Experimental grouping: experimental group: egg membrane composite nano-silver film prepared in Example 1; control group: egg membrane treated with sterile filter paper hydrochloric acid, egg membrane treated with dopamine solution;
(2)按实施例6中方法将各组薄膜制成无菌圆盘;(2) Make each group of films into sterile discs according to the method in Example 6;
(3)将大肠埃希菌和金黄色葡萄球菌的细菌悬液稀释为0.5个标准麦氏单位(106cfu/ml),再用无菌棉签蘸取菌液分别均匀涂布于MH琼脂培养皿上,每种菌株重复3个;(3) Dilute the bacterial suspension of Escherichia coli and Staphylococcus aureus to 0.5 standard McFarland units (106cfu/ml), and then dip the bacterial solution with a sterile cotton swab and spread it evenly on the MH agar culture dish , each strain was repeated 3 times;
(4)分别将各组薄膜圆盘小心置于MH琼脂培养皿上,并将培养皿放入37℃孵箱中;(4) Carefully place each group of film discs on the MH agar culture dish, and place the culture dish in a 37°C incubator;
(5)24小时后取出培养皿,拍照并记录。(5) Take out the petri dish after 24 hours, take pictures and record.
结果:参见图5,在大肠埃希菌和金黄色葡萄球菌培养皿中,鸡蛋膜复合纳米银薄膜的周围均出现了明显的抑菌环,说明其对两种细菌均具有良好的抗菌效果。Results: See Figure 5, in the culture dishes of Escherichia coli and Staphylococcus aureus, obvious antibacterial rings appeared around the egg membrane composite nano-silver film, indicating that it has good antibacterial effect on both bacteria.
实施例8;对制得的鸡蛋膜复合纳米银薄膜进行全层皮肤缺损创面修复实验Example 8: Carry out full-thickness skin defect wound repair experiment on the prepared egg membrane composite nano-silver film
(1)BALB/C小鼠(购自第三军医大学实验动物中心)全层皮肤缺损创面模型的制备:实验动物予以1%戊巴比妥钠腹腔注射(100mg/kg,0.01ml/g)麻醉。小鼠固定于俯卧位,背部术区备皮后,常规75%乙醇消毒。用打孔器于背部两侧各造一直径为4mm的全层皮肤缺损创面。取BALB/C小鼠35只,实验组和对照组各7只小鼠,均按上述方法制备创面模型。(1) Preparation of full-thickness skin defect wound model in BALB/C mice (purchased from the Experimental Animal Center of Third Military Medical University): The experimental animals were intraperitoneally injected with 1% pentobarbital sodium (100mg/kg, 0.01ml/g) anaesthetization. The mice were fixed in the prone position, and after the skin preparation of the back operation area, routine disinfection with 75% ethanol was performed. A full-thickness skin defect wound with a diameter of 4 mm was created on both sides of the back with a punch. Take 35 BALB/C mice, 7 mice in each of the experimental group and the control group, and prepare wound models according to the above method.
(2)实验组:将实施例1制备的鸡蛋膜复合纳米银薄膜样本裁剪为6×6mm大小,无菌生理盐水冲洗后,覆盖于小鼠背部创面上,再用负压吸引膜固定于背部皮肤;对照组:分别用凡士林纱布、盐酸处理后鸡蛋膜、多巴胺处理后鸡蛋膜覆盖创面,再用负压吸引膜固定,而空白对照组只用负压吸引膜固定。(2) Experimental group: the egg membrane composite nano-silver film sample prepared in Example 1 was cut into a size of 6×6 mm, washed with sterile saline, covered on the wound on the back of the mouse, and then fixed on the back with a negative pressure suction film Skin; control group: Vaseline gauze, egg membrane treated with hydrochloric acid, and egg membrane treated with dopamine were used to cover the wound, and then fixed with negative pressure suction membrane, while the blank control group was fixed only with negative pressure suction membrane.
(3)术后立即拍照记录,并作为第0天的原始创面面积,然后于第3、7天打开各组小鼠创面检查愈合情况,并拍照记录。术后第7天拍照后,小鼠即采用断颈法处死。(3) Immediately after the operation, take pictures and record them as the original wound area on day 0, then open the wounds of mice in each group on days 3 and 7 to check the healing status, and take pictures and record them. After the photographs were taken on the 7th day after the operation, the mice were sacrificed by neck breaking.
(4)利用Image Pro Plus 6.0对第3、7天各组创面照片进行分析,计算残余创面面积(创缘所包围的面积),并按下式计算创面愈合率:(4) Image Pro Plus 6.0 was used to analyze the wound photos of each group on the 3rd and 7th days, and the residual wound area (the area surrounded by the wound margin) was calculated, and the wound healing rate was calculated according to the following formula:
创面愈合率=(原始创面面积-残余创面面积)/原始创面面积。Wound healing rate = (original wound area - residual wound area) / original wound area.
结果:参见图6,鸡蛋膜复合纳米银薄膜组创面未见均未见红肿及过敏现象,无渗出液、脓液及脓肿形成,术区组织未见充血、水肿及坏死。术后第3天,鸡蛋膜复合纳米银薄膜组较其余各组创面愈合率高,且与空白对照组及凡士林纱布组相比有统计学差异;术后第7天,鸡蛋膜复合纳米银薄膜组愈合率较其它四组均高,且具有统计学差异。该结果说明制得的用于人工皮肤的鸡蛋膜复合纳米银薄膜能显著促进创面愈合。Results: See Figure 6. There was no redness, swelling and allergies on the wound surface of the egg membrane composite nano-silver film group, no exudate, pus and abscess formation, and no hyperemia, edema and necrosis in the surgical area. On the 3rd day after operation, the wound healing rate of the egg membrane composite nano-silver film group was higher than that of the other groups, and there was a statistical difference compared with the blank control group and the Vaseline gauze group; on the 7th day after the operation, the egg membrane composite nano-silver film group The healing rate of the group was higher than that of the other four groups, and the difference was statistically significant. The results indicate that the prepared egg membrane composite nano-silver film for artificial skin can significantly promote wound healing.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610701664.XA CN106310385B (en) | 2016-08-23 | 2016-08-23 | A kind of preparation method and application of the eggshell membrane composite Nano Ag films for artificial skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610701664.XA CN106310385B (en) | 2016-08-23 | 2016-08-23 | A kind of preparation method and application of the eggshell membrane composite Nano Ag films for artificial skin |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106310385A true CN106310385A (en) | 2017-01-11 |
CN106310385B CN106310385B (en) | 2019-03-29 |
Family
ID=57742772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610701664.XA Active CN106310385B (en) | 2016-08-23 | 2016-08-23 | A kind of preparation method and application of the eggshell membrane composite Nano Ag films for artificial skin |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106310385B (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107050500A (en) * | 2017-03-29 | 2017-08-18 | 安徽月娇家具有限公司 | A kind of preparation method of the modified loofah sponge fiber dressing with cytothesis function |
CN107233609A (en) * | 2017-07-07 | 2017-10-10 | 中国人民解放军第三军医大学第附属医院 | A kind of cork wood lysozyme anti-infective dressing and preparation method and application |
CN107456599A (en) * | 2017-08-10 | 2017-12-12 | 魏泓 | Antibacterial giant salamander secretion biomembrane and its preparation method and application |
CN107739055A (en) * | 2017-11-02 | 2018-02-27 | 太原工业学院 | A kind of method that biological template method prepares nanometer titanium dioxide manganese material |
CN108114318A (en) * | 2018-01-16 | 2018-06-05 | 暨南大学 | A kind of eggshell membrane/hydroxyapatite composite material and preparation method and application |
KR102191912B1 (en) | 2020-03-31 | 2020-12-16 | 강경수 | Method for Egg Shell Membrane |
CN115970067A (en) * | 2023-01-17 | 2023-04-18 | 中山大学附属口腔医院 | Intelligent guided bone tissue regeneration membrane and preparation method and application thereof |
CN116440330A (en) * | 2023-04-12 | 2023-07-18 | 山东第一医科大学附属省立医院(山东省立医院) | Multifunctional anti-adhesion biological film and preparation method and application thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050077998A (en) * | 2004-01-30 | 2005-08-04 | 조종수 | Antibiotic silver-egg membrane protein complex, antibiotic material coated with silver-egg membrane protein complex and a method for preparing the same |
CN102719824A (en) * | 2012-06-12 | 2012-10-10 | 天津大学 | Dopamine-nanosilver composite coating and preparation method thereof |
CN104357814A (en) * | 2014-11-24 | 2015-02-18 | 重庆大学 | Titanium alloy containing antibacterial coating as well as preparation method and application thereof |
-
2016
- 2016-08-23 CN CN201610701664.XA patent/CN106310385B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050077998A (en) * | 2004-01-30 | 2005-08-04 | 조종수 | Antibiotic silver-egg membrane protein complex, antibiotic material coated with silver-egg membrane protein complex and a method for preparing the same |
CN102719824A (en) * | 2012-06-12 | 2012-10-10 | 天津大学 | Dopamine-nanosilver composite coating and preparation method thereof |
CN104357814A (en) * | 2014-11-24 | 2015-02-18 | 重庆大学 | Titanium alloy containing antibacterial coating as well as preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
周染云等: "鸡蛋膜治疗术中所致浅表性皮肤损伤的观察", 《南方护理学报》 * |
张进等: "载芦荟纳米银鸡蛋膜创口贴的制备", 《中国化学会第十四届胶体与界面化学会议论文摘要集-第1分会:表面界面与纳米结构材料》 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107050500A (en) * | 2017-03-29 | 2017-08-18 | 安徽月娇家具有限公司 | A kind of preparation method of the modified loofah sponge fiber dressing with cytothesis function |
CN107233609B (en) * | 2017-07-07 | 2020-06-19 | 中国人民解放军第三军医大学第一附属医院 | Balsa-lysozyme anti-infective dressing and preparation method and application thereof |
CN107233609A (en) * | 2017-07-07 | 2017-10-10 | 中国人民解放军第三军医大学第附属医院 | A kind of cork wood lysozyme anti-infective dressing and preparation method and application |
CN107456599A (en) * | 2017-08-10 | 2017-12-12 | 魏泓 | Antibacterial giant salamander secretion biomembrane and its preparation method and application |
CN107456599B (en) * | 2017-08-10 | 2020-09-01 | 魏泓 | Antibacterial giant salamander secretion biomembrane and preparation method and application thereof |
CN107739055A (en) * | 2017-11-02 | 2018-02-27 | 太原工业学院 | A kind of method that biological template method prepares nanometer titanium dioxide manganese material |
CN108114318A (en) * | 2018-01-16 | 2018-06-05 | 暨南大学 | A kind of eggshell membrane/hydroxyapatite composite material and preparation method and application |
CN108114318B (en) * | 2018-01-16 | 2021-03-19 | 暨南大学 | A kind of egg membrane/hydroxyapatite composite material and its preparation method and application |
KR102191912B1 (en) | 2020-03-31 | 2020-12-16 | 강경수 | Method for Egg Shell Membrane |
CN115970067A (en) * | 2023-01-17 | 2023-04-18 | 中山大学附属口腔医院 | Intelligent guided bone tissue regeneration membrane and preparation method and application thereof |
CN115970067B (en) * | 2023-01-17 | 2023-10-17 | 中山大学附属口腔医院 | Intelligent guiding bone tissue regeneration membrane and preparation method and application thereof |
CN116440330A (en) * | 2023-04-12 | 2023-07-18 | 山东第一医科大学附属省立医院(山东省立医院) | Multifunctional anti-adhesion biological film and preparation method and application thereof |
CN116440330B (en) * | 2023-04-12 | 2023-11-14 | 山东第一医科大学附属省立医院(山东省立医院) | A multifunctional anti-adhesion biofilm and its preparation method and application |
Also Published As
Publication number | Publication date |
---|---|
CN106310385B (en) | 2019-03-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106310385A (en) | Preparation method and application of egg shell membrane composite nano-silver thin film used for artificial skin | |
Alven et al. | Chitosan and cellulose-based hydrogels for wound management | |
Dharunya et al. | Curcumin cross-linked collagen aerogels with controlled anti-proteolytic and pro-angiogenic efficacy | |
CN113769156B (en) | Hybrid fiber sponge with functions of hemostasis and wound repair and preparation method thereof | |
CN110041536B (en) | Functional sericin hydrogel and preparation method and application thereof | |
Gholipour-Kanani et al. | Effect of tissue-engineered chitosan-poly (vinyl alcohol) nanofibrous scaffolds on healing of burn wounds of rat skin | |
CN109675112B (en) | Preparation method of human-derived acellular dermal matrix | |
CN111905143A (en) | A kind of multifunctional tissue adhesion crystal glue dressing and preparation method and application thereof | |
Rathinamoorthy et al. | In vivo–Wound healing studies of Leptospermum scoparium honey loaded chitosan bioactive wound dressing | |
CN110639050A (en) | Silk fibroin nanofiber and preparation method of silver-loaded antibacterial dressing based on silk fibroin nanofiber | |
CN110507842B (en) | Bacterial cellulose/hyaluronic acid/epsilon-polylysine functional dressing and preparation method thereof | |
CN110772379A (en) | Preparation method of composite nanofiber membrane loaded with nanoenzyme and wound surface application thereof | |
Chen et al. | High-efficiency antibacterial calcium alginate/lysozyme/AgNPs composite sponge for wound healing | |
CN118217445A (en) | Composite hydrogel for repairing skin wound and preparation method and application thereof | |
CN104327297A (en) | Porous nanometer silver polyurethane film applied to artificial skin and preparation method thereof | |
Liu et al. | Bacterial Cellulose‐Based Bandages with Integrated Antibacteria and Electrical Stimulation for Advanced Wound Management | |
WO2023206055A1 (en) | Modification and use of silk fibroin | |
CN109966540A (en) | A kind of preparation method and application of nanometer chitin composite calcium alginate medical dressing | |
CN207837915U (en) | A kind of low immune prototype wound dressing | |
Sun et al. | A nanofiber hydrogel derived entirely from ocean biomass for wound healing | |
Bhoopathy et al. | An investigation on bioderived sponges with hemostatic and photoluminescent properties for accelerating wound healing | |
CN209092278U (en) | A kind of compound antibacterial biological dural patch | |
CN118697933A (en) | Preparation method and use of self-healing medical hydrogel | |
CN103083721B (en) | Artificial skin graft for genipin immobilized activin B and preparation method thereof | |
CN115518201A (en) | Collagen-based artificial skin with three-layer composite structure and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |